Wipfli Financial Advisors’s AngioDynamics ANGO Stock Holding History

Wipfli Financial Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$9K	Buy	+441	New	+$9.68K	﹤0.01%	1867

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Wipfli Financial Advisors's ANGO Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in AngioDynamics (ANGO) in Q3 2022: 441 shares worth $9K. The stake represents ﹤0.01% of the portfolio and ranks #1867 among its holdings.

149 funds tracked by Wall St. Rank hold ANGO as of Q3 2022.

Wipfli Financial Advisors held 441 shares of AngioDynamics worth $9K as of Q3 2022.
AngioDynamics was a new Wipfli Financial Advisors position in Q3 2022.
AngioDynamics made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #1867 holding.
149 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.